UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 102

Sortiert nach

Diagnosis and treatment of basal cell carcinoma: European consensus–based interdisciplinary guidelines

European journal of cancer (1990), 2019-09, Vol.118, p.10-34

2019

Volltextzugriff (PDF)

Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline – Update 2016

European journal of cancer (1990), 2016-08, Vol.63, p.201-217

2016

Volltextzugriff (PDF)

Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline

European journal of cancer (1990), 2015-09, Vol.51 (14), p.1989-2007

2015

Volltextzugriff (PDF)

Diagnosis and treatment of dermatofibrosarcoma protuberans. European consensus-based interdisciplinary guideline

European journal of cancer (1990), 2015-11, Vol.51 (17), p.2604-2608

2015

Volltextzugriff (PDF)

Development of an Image Analysis-Based Prognosis Score Using Google's Teachable Machine in Melanoma

Cancers, 2022-04, Vol.14 (9), p.2243

2022

Volltextzugriff (PDF)

Peripheral PD-1+CD56+ T-cell frequencies correlate with outcome in stage IV melanoma under PD-1 blockade

PloS one, 2019-08, Vol.14 (8), p.e0221301-e0221301

2019

Volltextzugriff (PDF)

Diffuse PRAME Expression Is Highly Specific for Thin Melanomas in the Distinction from Severely Dysplastic Nevi but Does Not Distinguish Metastasizing from Non-Metastasizing Thin Melanomas

Cancers, 2021-07, Vol.13 (15), p.3864

2021

Volltextzugriff (PDF)

Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies

Journal for immunotherapy of cancer, 2019-12, Vol.7 (1), p.343-343, Article 343

2019

Volltextzugriff (PDF)

Serum S100B, lactate dehydrogenase and brain metastasis are prognostic factors in patients with distant melanoma metastasis and systemic therapy

PloS one, 2013-11, Vol.8 (11), p.e81624-e81624

2013

Volltextzugriff (PDF)

Prognostic role of gamma-glutamyl transferase in metastatic melanoma patients treated with immune checkpoint inhibitors

Cancer Immunology, Immunotherapy, 2021-04, Vol.70 (4), p.1089-1099

2021

Volltextzugriff (PDF)

The natural course of cutaneous melanoma

Journal of surgical oncology, 2004-07, Vol.86 (4), p.172-178

2004

Volltextzugriff (PDF)

Association between Immune-Related Adverse Events and Survival in 319 Stage IV Melanoma Patients Treated with PD-1-Based Immunotherapy: An Approach Based on Clinical Chemistry

Cancers, 2021-12, Vol.13 (23), p.6141

2021

Volltextzugriff (PDF)

Survival according to BRAF-V600 tumor mutations--an analysis of 437 patients with primary melanoma

PloS one, 2014-01, Vol.9 (1), p.e86194-e86194

2014

Volltextzugriff (PDF)

Quantitative measurement of melanoma spread in sentinel lymph nodes and survival

PLoS medicine, 2014-02, Vol.11 (2), p.e1001604-e1001604

2014

Volltextzugriff (PDF)

Primary localization and tumor thickness as prognostic factors of survival in patients with mucosal melanoma

PloS one, 2014-11, Vol.9 (11), p.e112535-e112535

2014

Volltextzugriff (PDF)

Analysis of BRAF and NRAS Mutation Status in Advanced Melanoma Patients Treated with Anti-CTLA-4 Antibodies: Association with Overall Survival?

PloS one, 2015-10, Vol.10 (10), p.e0139438-e0139438

2015

Volltextzugriff (PDF)

BRAF-V600 mutations have no prognostic impact in stage IV melanoma patients treated with monochemotherapy

PloS one, 2014-02, Vol.9 (2), p.e89218

2014

Volltextzugriff (PDF)

Prognostic Factors of Thin Cutaneous Melanoma: An Analysis of the Central Malignant Melanoma Registry of the German Dermatological Society

Journal of clinical oncology, 2004-09, Vol.22 (18), p.3660-3667

2004

Volltextzugriff (PDF)

Incisional biopsy and melanoma prognosis: Facts and controversies

Clinics in dermatology, 2010-05, Vol.28 (3), p.316-318

2010

Volltextzugriff (PDF)

The Prognostic and Predictive Value of Melanoma-related MicroRNAs Using Tissue and Serum: A MicroRNA Expression Analysis

EBioMedicine, 2015-07, Vol.2 (7), p.671-680

2015

Volltextzugriff (PDF)

Early disappearance of tumor antigen-reactive T cells from peripheral blood correlates with superior clinical outcomes in melanoma under anti-PD-1 therapy

Journal for immunotherapy of cancer, 2021-12, Vol.9 (12), p.e003439

2021

Volltextzugriff (PDF)

Prognostic factors of melanoma patients with satellite or in-transit metastasis at the time of stage III diagnosis

PloS one, 2013-04, Vol.8 (4), p.e63137-e63137

2013

Volltextzugriff (PDF)

Melanoma patients with unknown primary site or nodal recurrence after initial diagnosis have a favourable survival compared to those with synchronous lymph node metastasis and primary tumour

PloS one, 2013-06, Vol.8 (6), p.e66953-e66953

2013

Volltextzugriff (PDF)

1 – 25 von 102

Suche als RSS-Feed

Aktive Filter

ThemaPrognosis

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(98)
Mit Volltextzugriff
(97)

Publikationsform

Artikel
(101)
Buchkapitel
(1)

Sprache

Englisch
(99)
Japanisch
(14)
Deutsch
(4)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Diagnosis and treatment of basal cell carcinoma: European consensus–based interdisciplinary guidelines

Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline – Update 2016

Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial

Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline

Binimetinib versus dacarbazine in patients with advanced NRAS -mutant melanoma (NEMO): a multicentre, open-label, randomised, phase 3 trial

Diagnosis and treatment of dermatofibrosarcoma protuberans. European consensus-based interdisciplinary guideline

Development of an Image Analysis-Based Prognosis Score Using Google's Teachable Machine in Melanoma

Peripheral PD-1+CD56+ T-cell frequencies correlate with outcome in stage IV melanoma under PD-1 blockade

Diffuse PRAME Expression Is Highly Specific for Thin Melanomas in the Distinction from Severely Dysplastic Nevi but Does Not Distinguish Metastasizing from Non-Metastasizing Thin Melanomas

Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies

Serum S100B, lactate dehydrogenase and brain metastasis are prognostic factors in patients with distant melanoma metastasis and systemic therapy

Prognostic role of gamma-glutamyl transferase in metastatic melanoma patients treated with immune checkpoint inhibitors

The natural course of cutaneous melanoma

Association between Immune-Related Adverse Events and Survival in 319 Stage IV Melanoma Patients Treated with PD-1-Based Immunotherapy: An Approach Based on Clinical Chemistry

Survival according to BRAF-V600 tumor mutations--an analysis of 437 patients with primary melanoma

Quantitative measurement of melanoma spread in sentinel lymph nodes and survival

Primary localization and tumor thickness as prognostic factors of survival in patients with mucosal melanoma

Analysis of BRAF and NRAS Mutation Status in Advanced Melanoma Patients Treated with Anti-CTLA-4 Antibodies: Association with Overall Survival?

BRAF-V600 mutations have no prognostic impact in stage IV melanoma patients treated with monochemotherapy

Prognostic Factors of Thin Cutaneous Melanoma: An Analysis of the Central Malignant Melanoma Registry of the German Dermatological Society

Incisional biopsy and melanoma prognosis: Facts and controversies

The Prognostic and Predictive Value of Melanoma-related MicroRNAs Using Tissue and Serum: A MicroRNA Expression Analysis

Early disappearance of tumor antigen-reactive T cells from peripheral blood correlates with superior clinical outcomes in melanoma under anti-PD-1 therapy

Prognostic factors of melanoma patients with satellite or in-transit metastasis at the time of stage III diagnosis

Melanoma patients with unknown primary site or nodal recurrence after initial diagnosis have a favourable survival compared to those with synchronous lymph node metastasis and primary tumour

Aktive Filter

Suchergebnisse filtern